Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis
Evaluation of Omega-3 Polyunsaturated Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Generalized Aggressive Periodontitis: Randomized Controlled Clinical Trial
Sponsor: Universidade Estadual Paulista Júlio de Mesquita Filho
This PHASE2/PHASE3 trial investigates Aggressive Periodontitis and Residual Disease and is currently completed. Universidade Estadual Paulista Júlio de Mesquita Filho leads this study, which shows 15 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2/PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE2_PHASE3
▶ Show 10 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE2_PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
-
Sep 2020 — Dec 2020 [monthly]
Completed PHASE2_PHASE3
Status: Active Not Recruiting → Completed
-
Feb 2020 — Sep 2020 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Dec 2019 — Feb 2020 [monthly]
Active Not Recruiting PHASE2_PHASE3
Status: Recruiting → Active Not Recruiting
-
Jul 2019 — Dec 2019 [monthly]
Recruiting PHASE2_PHASE3
Status: Unknown Status → Recruiting
-
Jun 2019 — Jul 2019 [monthly]
Unknown Status PHASE2_PHASE3
Status: Recruiting → Unknown Status
-
Jun 2018 — Jun 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Jun 2017 — Jun 2018 [monthly]
Recruiting PHASE2_PHASE3
Status: Not Yet Recruiting → Recruiting
-
May 2017 — Jun 2017 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Universidade Estadual Paulista Júlio de Mesquita Filho
For direct contact, visit the study record on ClinicalTrials.gov .